Latest News
BlackRock Real Assets has entered into an agreement to purchase GE Energy Financial Services’ 50 per cent interest in the Grandview wind project (Grandview).
Grandview is now jointly owned by BlackRock and E.ON Climate and Renewables North America (EC&RNA), a subsidiary of E.ON SE, one of the world’s largest renewable power providers.
Grandview has been operating since December, 2014 and is located on 45,000 acres in Carson County, Texas in the ERCOT regional transmission origination system. The 211 MW wind project will supply electricity to the region under a long-term offtake agreement with an investment grade counterparty and utilises proven,
Arma Partners has acted as exclusive financial advisor to MSI Holding AB (AddSecure), a portfolio company of GMT Communications Partners and Viking Venture AS, on its sale to ABRY Partners.
Headquartered in Stockholm, AddSecure is the Nordic market leader providing secure mission-critical M2M communications for security and other applications across a wide range of verticals including healthcare, public safety, transportation and utilities. The company manages a highly secure communications platform enabling the automated control and remote monitoring and management of sensors and other devices deployed in the field. Employing 120 people in Scandinavia, AddSecure has more than 100,000 business clients.
Law firm, Mourant Ozannes, has advised 3i Infrastructure on the successful completion of a capital raise with gross proceeds of GBP385 million.
3i Infrastructure plc is a FTSE 250 infrastructure investment company. Capital raised will be used to fund the completion of the company's investments in Wireless Infrastructure Group and TCR and invest in further new investments during the rest of the financial year.
The offering, with an original target size of GBP350 million, was significantly oversubscribed and the final size has been set so as to ensure that the Company continues to maintain an efficient balance sheet while at
Leading international law firm, Mourant Ozannes, has advised long standing client Intertrust N.V. on its GBP435 million acquisition of Elian Group.
Netherlands-based global trust and corporate services provider, Intertrust NV, has 37 offices in 26 jurisdictions in Europe, Asia and the Middle East. Fiduciary services company Elian, which has its headquarters in Jersey, comprises 15 offices around the world.
Mourant Ozannes Partner, Simon Felton, says: "This is a positive step for Intertrust and Elian which will allow for significant growth and diversification in key jurisdictions, creating a truly global leader in their industry. Our international team of specialists worked together
British Business Bank Investments, the commercial arm of the British Business Bank, has appointed Catherine Lewis La Torre as Chief Executive Officer, effective from 1 September 2016.
Lewis La Torre joins British Business Bank Investments from Cardano, where she is Head of Private Equity and responsible for managing a portfolio of private capital fund investments with over GBP1 billion of client commitments. This appointment follows the announcement that Peter Wilson was stepping down as CEO in March 2016.
Lewis La Torre has over thirty years’ experience in the private equity industry focused on investing in the European mid-market. Before
Navicure, a provider of cloud-based claims management and patient payment solutions for physician practices and hospitals, has secured a strategic investment from Bain Capital Private Equity. Financial terms of the private transaction have not been disclosed.
Navicure, which is headquartered in Duluth, Georgia, will continue to be led by current CEO and founder, James M. Denny, Jr. and his executive team. They will retain a meaningful interest in the business. Selling shareholders include JMI Equity and other minority investors.
Navicure’s subscription-based software solutions help healthcare organisations of all sizes increase revenue, accelerate cash flow, and reduce the costs associated with
Didier Patry has been appointed Chief Executive Officer of France Brevets. He reports to the Board of Directors chaired by Philippe Caïla.
Patry succeeds Jean-Charles Hourcade who has decided to pursue other career interests. Jean-Charles Hourcade will provide him with full support in this transition period and will continue to support some of France Brevets’ strategic initiatives.
“I would like to thank Jean-Charles Hourcade for his professionalism and commitment over these last five years. France Brevets is today a major player in the monetisation of intellectual property and patent portfolios of European companies. Patents must remain more than ever in
YFM Equity Partners has launched its new YFM Equity Partners 2016 Fund (YFMEP 2016), which will provide investors with the opportunity to participate in YFM’s future private equity investments which no longer qualify for VCT investment.
YFM has already secured GBP22 million from existing pension funds and new family office backers in the last three months and following this early success are now focussing on the next stage of fundraising. The team is looking to raise an additional GBP10-15m of private equity capital to be invested over YFMEP 2016’s two-year investment period. YFMEP 2016 complements YFM’s established VCT funds, increasing
Private equity firm Warburg Pincus has appointed Stefan Krause as a Senior Advisor. He will support the firm in the identification and evaluation of new investments in Europe.
Krause has over twenty years of experience as a senior executive leading international businesses headquartered in Germany. Most recently he served as Chief Financial Officer and Member of Management Board of Deutsche Bank, Germany’s largest bank. Prior to his time at Deutsche Bank, Mr. Krause served in several management positions at Bayerische Motoren Werke Aktiengesellschaft (also known as BMW Group) in Germany and the United States, including as Chief Financial Officer.
René
Tikehau IM has acted as sole lead arranger of a EUR35 million unitranche denominated in USD for the acquisition of Cisbio Bioassays by Abénex.
Abénex acquires Cisbio Bioassays in a secondary LBO from Argos Soditic. Flexible unitranche financing denominated in US$ has been arranged by Tikehau IM.
Cisbio Bioassays is a French life sciences company committed to improving human healthcare. With more than 30 years of experience in in vitro diagnostics and drug discovery, Cisbio Bioassays provides creative technological solutions by partnering with the global scientific community in Codolet (France). Its portfolio of over 460 proprietary assays and reagents is
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
